MENU
REGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Regeneron Pharmaceuticals (REGN) Ownership - Who owns Regeneron Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
85.99B
P/E Ratio
19.35
Total Cash
9.8B
Projected Growth
1.16
Total Debt
2.7B
Revenue
13.85B
Risk (Beta)
0.37
Dividend Yield
N/A
Total Cash/Share
89.15
Total Debt/Equity
24.02
Revenue/Share
120.28 USD as % of share price
Fundamentals
REGN
Capitalization
86B
P/E Ratio
19.35
Risk (Beta)
0.37
Dividend Yield
N/A
Total Cash
9.8B
Total Cash/Share
89.15
Total Debt
2.7B
Total Debt/Equity
24.02
Projected Growth (PEG Ratio)
1.16
Revenue/Share (as % of the share price)
120.28%
Revenue
13.8B
ROE
N/A
Book Value
29.3B
P/B Ratio
2.93
Cash Flow
N/A
Earnings
43.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
5.28
Current Revenue Per Employee
262464.72
Dividends Per Share - Security
N/A
EBITDA
5.5B
Float
N/A
Float - Current
N/A
Gross Income Margin
86.80
Revenue To Assets
13.37
Shares Held By Institutions
278B
Shares Outstanding - Current
110M
Total Liabilities
8.12B
Total Volume MTD
N/A
Value
-1
Gain YTD
-10.905
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of medicines for the treatment of serious medical conditions
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com